United States· US:79974-216_e4a7ecde-0c1a-43da-8488-1f31b106c2dc
Mamisan
A medicinal product containing lidocaine hydrochloride; menthol, unspecified form, registered in United States by Miramar Cosmetics, Inc DBA Miramar Lab.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- LIDOCAINE HYDROCHLORIDE; MENTHOL, UNSPECIFIED FORM
- Manufacturer
- Miramar Cosmetics, Inc DBA Miramar Lab
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1179974-216-03
- ndc117997421603100 g in 1 JAR (79974-216-03)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f772417c-37ed-4d31-bde9-9a6eeb522c10 GET /v1/drugs/f772417c-37ed-4d31-bde9-9a6eeb522c10?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "4; 1",
"substance": "LIDOCAINE HYDROCHLORIDE; MENTHOL, UNSPECIFIED FORM",
"productndc": "79974-216",
"dosage_form": "OINTMENT",
"dea_schedule": null,
"strength_unit": "g/100g; g/100g",
"application_number": "M017",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about lidocaine hydrochloride; menthol, unspecified form.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.